Doravirine
Back to searchMolecule Structure
Scientific Name
Doravirine
Description of the Drug
Doravirine is a non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12301
http://www.drugbank.ca/drugs/DB12301
Brand Name(s)
Pifeltro
Company Owner(s)
Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | NEGATIVE ALLOSTERIC MODULATOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2509885 | |
| Human Metabolome Database | HMDB0251589 | |
| DrugBank | DB12301 | |
| PubChem | 58460047 | |
| Nikkaji | J3.400.426I | |
| PDBe | 2KW | |
| BindingDB | 50508293 | |
| EPA CompTox Dashboard | DTXSID30158386 | |
| DrugCentral | 5295 | |
| ChemicalBook | CB92516043 | |
| rxnorm | PIFELTRO | DORAVIRINE |
| ZINC | ZINC000072317283 |
